IRCT2015121425526N1Completed未知
Effects of N-acetylcysteine on the quality of life, anxiety and antioxidant indexes of patients with cardiovascular disease.
orestan University of Medical Sciences0 sites120 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 120
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 65 years (—)
- Sex
- All
Inclusion Criteria
- •1. patients with acute coronary syndrome, coronary artery disease, the treating physician to confirm the diagnosis reached.
- •2 people (women and men) aged 65-18 years able to read and write their own.
- •3. People who have the full consent to participate in research.
- •4. People who have a history of these-acetylcysteine ??orally, by injection or inhalation during the first months of treatment have not.
- •5 people without a history of hypersensitivity reactions after taking it approved acetylcysteine
- •6. The people who received both medications or substances with antioxidant effects as vitamin E, A or vitamin A, E, vitamin C, at least one month before the quake
- •7. People with a history of anti-anxiety drugs, have.
- •8 people aged 65-18 years.
- •9. The lack of disease HCV +, HBSAg +, HIV +, diabetes, kidney disease,
- •10 of pregnancy
- •Exclusion criteria
- •(1) patients who can not understand the questions or did not have the time and location aware.
- •2. Patients in the study were dissatisfied.
- •3. Patients who withdrew during the study.
- •4. People who do not consume drugs.
- •5 people who died during the study.
- •6. Individuals involved in the research program to improve the quality of life or reduce anxiety, such as health promotion, and rehabilitation and so on are.
- •7 people in the business week by experts and researchers to track the phone call not to participate or not.
- •8. ejection fraction less than 40% for the echocardiogram
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Phase 3
The Evaluation of the Effect of N-acetylcysteine in Improving Methadone PoisoningPoisoning by Methadone.Poisoning by Methadone, undeterminedT40.3X4IRCT20210222050462N1Shahre-kord University of Medical Sciences64
Not yet recruiting
Phase 3
Investigation of the effect of N-acetylcysteine in rheumatoid arthritisRheumatoid arthritis.Rheumatoid arthritis with rheumatoid factorIRCT20101014004934N2Kashan University of Medical Sciences74
Completed
Phase 3
The effect of N-acetylcysteine ??(NAC) on renal failure in Coronary surgeryPatients undergoing open heart surgery.IRCT20200823048491N1Esfahan University of Medical Sciences100
Completed
Phase 3
Effects of N-acetylcysteine administration in treatment of women with gestational diabetes mellitusGestational diabetes mellitus.Unspecified diabetes mellitus in pregnancy, childbirth and the puerperiumO24.9IRCT20170513033941N71Kashan University of Medical Sciences76
Completed
Phase 3
Study of the Effect of N-acetylcysteine on Urinary Tract Infection in Children.IRCT2013112015465N1Shahid Beheshti Medical University, Faculty of Pharmacy64
